Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Synthesis and Evaluation of Astatinated N-[2-(Maleimido)ethyl]-3-(trimethylstannyl)benzamide Immunoconjugates

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Molecular Targeted NIR-II Probe for Image-Guided Brain Tumor Surgery

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Preclinical Study on GRPR-Targeted (68)Ga-Probes for PET Imaging of Prostate Cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. NMR characterization of the DNA binding properties of a novel Hoechst 33258 analogue peptide building block

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Concerted intercalation and minor groove recognition of DNA by a homodimeric thiazole orange dye

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Extraction of 211At from nitric acid solutions into various organic solvents for use as an α-source for radiation chemistry studies

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Absorbed Doses and Risk Estimates of (211)At-MX35 F(ab')2 in Intraperitoneal Therapy of Ovarian Cancer Patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. N-[2-(maleimido)ethyl]-3-(trimethylstannyl)benzamide, a molecule for radiohalogenation of proteins and peptides

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Shelf-life of ɛ-lysyl-3-(trimethylstannyl)benzamide immunoconjugates, precursors for 211At labeling of antibodies

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Emma Aneheim
  • Anna Gustafsson
  • Per Albertsson
  • Tom Bäck
  • Holger Jensen
  • Stig Palm
  • Sofia Svedhem
  • Sture Lindegren
View graph of relations

Effective treatment of metastasis is a great challenge in the treatment of different types of cancers. Targeted alpha therapy utilizes the short tissue range (50-100 μm) of α particles, making the method suitable for treatment of disseminated occult cancers in the form of microtumors or even single cancer cells. A promising radioactive nuclide for this type of therapy is astatine-211. Astatine-211 attached to tumor-specific antibodies as carrier molecules is a system currently under investigation for use in targeted alpha therapy. In the common radiolabeling procedure, astatine is coupled to the antibody arbitrarily on lysine residues. By instead coupling astatine to disulfide bridges in the antibody structure, the immunoreactivity of the antibody conjugates could possibly be increased. Here, the disulfide-based conjugation was performed using a new coupling reagent, maleimidoethyl 3-(trimethylstannyl)benzamide (MSB), and evaluated for chemical stability in vitro. The immunoconjugates were subsequently astatinated, resulting in both high radiochemical yield and high specific activity. The MSB-conjugate was shown to be stable with a long shelf life prior to the astatination. In a comparison of the in vivo distribution of the new immunoconjugate with other tin-based immunoconjugates in tumor-bearing mice, the MSB conjugation method was found to be a viable option for successful astatine labeling of different monoclonal antibodies.

Original languageEnglish
JournalBioconjugate Chemistry
Volume27
Issue number3
Pages (from-to)688-97
Number of pages10
ISSN1043-1802
DOIs
Publication statusPublished - 16 Mar 2016

    Research areas

  • Animals, Astatine, Benzamides, Immunoconjugates, Mice, Mice, Inbred BALB C, Journal Article, Research Support, Non-U.S. Gov't

ID: 49714253